SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000891836-11-000164
Filing Date
2011-11-08
Accepted
2011-11-08 10:42:04
Documents
2
Group Members
ANDREW H. TISCHDANIEL R. TISCHJAMES S. TISCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc0081.htm SC 13D 118430
2 JOINT FILING AGREEMENT ex_99-1.htm EX-99.1 7526
  Complete submission text file 0000891836-11-000164.txt   127452
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-52299 | Film No.: 111186614
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE NEW YORK NY 10021
Business Address
TISCH THOMAS J (Filed by) CIK: 0001081916 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D